RARE vs UNIT · rev $560.2M vs P/E 2.7, rev $722.6M
Ultragenyx (RARE) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
RARE currently screens at market cap $2.79B. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the RARE and UNIT stock pages for the full models.
Not investment advice.